261 related articles for article (PubMed ID: 22704957)
1. The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells.
Florio T; Barbieri F
Drug Discov Today; 2012 Oct; 17(19-20):1103-10. PubMed ID: 22704957
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma stem cells.
Tabatabai G; Weller M
Cell Tissue Res; 2011 Mar; 343(3):459-65. PubMed ID: 21253762
[TBL] [Abstract][Full Text] [Related]
3. Glioma stem cell signaling: therapeutic opportunities and challenges.
Dietrich J; Diamond EL; Kesari S
Expert Rev Anticancer Ther; 2010 May; 10(5):709-22. PubMed ID: 20470003
[TBL] [Abstract][Full Text] [Related]
4. IQGAP1 protein specifies amplifying cancer cells in glioblastoma multiforme.
Balenci L; Clarke ID; Dirks PB; Assard N; Ducray F; Jouvet A; Belin MF; Honnorat J; Baudier J
Cancer Res; 2006 Sep; 66(18):9074-82. PubMed ID: 16982749
[TBL] [Abstract][Full Text] [Related]
5. IGFBP2 promotes glioma tumor stem cell expansion and survival.
Hsieh D; Hsieh A; Stea B; Ellsworth R
Biochem Biophys Res Commun; 2010 Jun; 397(2):367-72. PubMed ID: 20515648
[TBL] [Abstract][Full Text] [Related]
6. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
7. RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival.
Goidts V; Bageritz J; Puccio L; Nakata S; Zapatka M; Barbus S; Toedt G; Campos B; Korshunov A; Momma S; Van Schaftingen E; Reifenberger G; Herold-Mende C; Lichter P; Radlwimmer B
Oncogene; 2012 Jul; 31(27):3235-43. PubMed ID: 22056879
[TBL] [Abstract][Full Text] [Related]
8. Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells.
Beck S; Jin X; Yin J; Kim SH; Lee NK; Oh SY; Jin X; Kim MK; Kim EB; Son JS; Kim SC; Nam DH; Kim SH; Kang SK; Kim H; Choi YJ
Biomaterials; 2011 Nov; 32(33):8518-28. PubMed ID: 21880363
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma and stem cells.
Altaner C
Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
[TBL] [Abstract][Full Text] [Related]
10. Brain tumor stem cells as research and treatment targets.
Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
[TBL] [Abstract][Full Text] [Related]
11. Improving the radiosensitivity of radioresistant and hypoxic glioblastoma.
Sheehan JP; Shaffrey ME; Gupta B; Larner J; Rich JN; Park DM
Future Oncol; 2010 Oct; 6(10):1591-601. PubMed ID: 21062158
[TBL] [Abstract][Full Text] [Related]
12. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W
Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
[TBL] [Abstract][Full Text] [Related]
15. Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview.
Chu PM; Ma HI; Chen LH; Chen MT; Huang PI; Lin SZ; Chiou SH
Cell Transplant; 2013; 22(4):741-53. PubMed ID: 23127968
[TBL] [Abstract][Full Text] [Related]
16. The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.
Landis CJ; Tran AN; Scott SE; Griguer C; Hjelmeland AB
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):175-188. PubMed ID: 29378228
[TBL] [Abstract][Full Text] [Related]
17. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy targeting glioma stem cells--insights and perspectives.
Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
[TBL] [Abstract][Full Text] [Related]
19. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.
Günther HS; Schmidt NO; Phillips HS; Kemming D; Kharbanda S; Soriano R; Modrusan Z; Meissner H; Westphal M; Lamszus K
Oncogene; 2008 May; 27(20):2897-909. PubMed ID: 18037961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
